The University of Rochester is hosting a symposium that will examine the impact of genomic research and emerging technologies on medicine. The Genomics and Translational Medicine Symposium – which will be held October 22-23, 2009 – is co-sponsored by the University’s Clinical and Translational Science Institute and the Office of Corporate Alliances.
The advent of high-speed, low-cost genome sequencing technology, molecular-based imaging, and other emerging tools has accelerated understanding of the role of genetics in human health and hold the potential to help scientists identify new ways to understand, prevent, treat, and potentially cure a myriad of diseases. These new technologies are also central to ongoing efforts to develop treatment approaches that are tailored to individual patients, an emerging field known as personalized medicine.
The University of Rochester symposium will explore both the potential and the challenges associated with the field of genomics, focusing on efforts to translate discoveries and emerging technologies into new medical applications. Panels consisting of speakers from government, academia, and industry will address topics such as human genome research, bioinformatics, health computing, diagnostics and therapeutics, and broader policy issues.
The Genomics and Translational Medicine Symposium will be held October 22-23, 2009 in the Class of ’62 Auditorium at the University of Rochester School of Medicine and Dentistry. The symposium is free and open to the public. Participants are requested to register by October 9. Registration information and the symposium agenda are available on the Office of Corporate Alliances website at www.urmc.rochester.edu/oca.